But many projects come under public and federal scrutiny — the recent fracas
over gene therapy trials is a case in point (Science, 24 March, p. 2163), often because the manner in which they were conducted led to concerns over the safety of the recruited participants or the protection of their confidentiality.
Gene and cell
therapies have made important medical advances
over the past three decade, developing technologies and testing novel
therapies in multiple human clinical
trials of many diseases.